These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Wang ZL; Zhang X; Xu X; Sun XD; Wang F Retina; 2005 Jan; 25(1):38-43. PubMed ID: 15655439 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacologic vitreolysis in diabetic rats]. Luo M; Wang ZL; Shi WD; Fan XQ; Xu GT Zhonghua Yan Ke Za Zhi; 2009 May; 45(5):417-23. PubMed ID: 19576064 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats. Zhi-Liang W; Wo-Dong S; Min L; Xiao-Ping B; Jin J Retina; 2009 Feb; 29(2):269-74. PubMed ID: 19050667 [TBL] [Abstract][Full Text] [Related]
6. Intrasurgical plasmin enzyme in diabetic macular edema. Gandorfer A; Kampik A Am J Ophthalmol; 2005 May; 139(5):949; author reply 949-50. PubMed ID: 15860323 [No Abstract] [Full Text] [Related]
7. Pharmacologic vitreolysis. Gandorfer A Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084 [TBL] [Abstract][Full Text] [Related]
11. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes]. Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060 [TBL] [Abstract][Full Text] [Related]
12. Long-term effect of plasmin on the vitreolysis in rabbit eyes. Kim NJ; Yu HG; Yu YS; Chung H Korean J Ophthalmol; 2004 Jun; 18(1):35-40. PubMed ID: 15255235 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological vitrectomy. Tanaka M; Qui H Semin Ophthalmol; 2000 Mar; 15(1):51-61. PubMed ID: 10749315 [TBL] [Abstract][Full Text] [Related]
14. Intrasurgical plasmin enzyme in diabetic macular edema. Azzolini C; D'Angelo A; Maestranzi G; Codenotti M; Della Valle P; Prati M; Brancato R Am J Ophthalmol; 2004 Oct; 138(4):560-6. PubMed ID: 15488781 [TBL] [Abstract][Full Text] [Related]
16. Knowledge of vitreomacular traction (VMT) scenarios: Is doing nothing still a beneficial alternative and, if so, when? Ziemssen F; Bartz-Schmidt KU; Dimopoulos S Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):615-6. PubMed ID: 26887826 [No Abstract] [Full Text] [Related]
17. Experimental evaluation of microplasmin - an alternative to vital dyes. Gandorfer A Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388 [TBL] [Abstract][Full Text] [Related]
18. Molecular biology of pharmacologic vitreolysis. Sebag J Trans Am Ophthalmol Soc; 2005; 103():473-94. PubMed ID: 17057814 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic vitreolysis--premise and promise of the first decade. Sebag J Retina; 2009; 29(7):871-4. PubMed ID: 19584647 [No Abstract] [Full Text] [Related]